Lecithin vesicles for oral delivery
Giant multi-lamellar vesicles (GMVs) comprising lecithin are provided which are at least about 3 μm in size. Methods for preparing the GMVs, and for preparing large unilamellar vesicles (LUVs) from the GMVs, are provided, as well as methods for encapsulating cargo within the GMVs and LUVs. The present vesicles are useful for the oral delivery of encapsulated cargo.
1. Giant multi-lamellar vesicles in the size range of 3-10 μm which consist of deoiled lecithin, wherein the lecithin comprises phosphatidylcholines in an amount in the range of about 15-50% by wt, phosphatidylethanolamines in an amount in the range of about 5-25 wt % and phosphatidic acids in an amount of less than 10% by wt.
2. The vesicles of claim 1 , wherein the lecithin comprises a phosphatidylcholine to phosphatidylethanolamine (PC:PE) ratio of in the range of about 1:1 to 5:1 PC:PE.
3. The vesicles of claim 1 , wherein the lecithin comprises a PC:PE molar or mass ratio of greater than 1.
4. The vesicles of claim 1 , wherein the lecithin comprises about 5-15% by wt phosphatidylethanolamines.
5. The vesicles of claim 1 , which are in a liquid crystalline state over the temperature range 0-90° C.
6. The vesicles of claim 1 , prepared by mixing the lecithin in a buffer until fully dispersed.
7. The vesicles of claim 6 , wherein lecithin in an amount of about 2-20% by wt is mixed with the buffer.
8. The vesicles of claim 6 , wherein the buffer is an acidic buffer.
9. The vesicles of claim 7 , wherein lecithin in an amount of 10% (w/w) is mixed with buffer at a pH that is equal to or greater than the effective pK of the phosphate group of the phospholipid mixture in the lecithin.
10. The vesicles of claim 1 , comprising encapsulated cargo.
11. The vesicles of claim 10 , comprising a cargo to lecithin ratio of at least 1:5 mol:mol.
12. The vesicles of claim 10 , wherein the cargo comprises a cannabinoid.
13. The vesicles of claim 12 , wherein the cannabinoid is selected from the group consisting of: cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabichromenic acid (CBCA), cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabigerol (CBG), cannabigerolic acid (CBGA), cannabigerivarin (CBGV), cannabidivarin acid (CBDVA), cannabinovarin (CBNV), cannabinodiol (CBDL), cannabicyclol (CBL), cannabielsoin (CBE), cannabitriol (CBT), cannabivarin (CBV), cannabichromevarin (CBCV), cannabigerol monoethyl ether (CBGM), tetrahydrocannabinols (THC), tetrahydrocannabivarin (THCV), naphthoylindoles; phenylacetylindoles; benzoylindoles; cyclohexylphenoles; and HU-210.
14. The vesicles of claim 10 , wherein the cargo comprises a terpene.
15. The vesicles of claim 13 , additionally comprising an antioxidant.
16. The vesicles of claim 15 , wherein the antioxidant is a phenolic antioxidant.
17. The vesicles of claim 16 , wherein the phenolic antioxidant is tert-butyl hydroxy quinone (TBHQ), butylated hydroxy toluene (BHT), butylated hydroxyl anisole (BHA), propyl gallate (PG), a tocopherol or a mixture thereof.
18. The vesicles of claim 10 , prepared by dissolving the cargo in a solvent and mixing with preformed giant multi-lamellar vesicles having a size of at least 3 μm for a time sufficient for uptake of the cargo.
19. A method of preparing the vesicles of claim 1 , comprising mixing the deoiled lecithin in an aqueous buffer until fully dispersed.
20. The method of claim 19 , wherein the pH of the buffer is between about 2.5-5 and the method is conducted at a temperature in the range of between 55-75° C.
21. A method of preparing large unilamellar vesicles (LUVs) having a size in the range of about 100-400 nm comprising the step of exposing giant multi-lamellar vesicles (GMVs) as defined in claim 1 to mixing in range of about 10000-30000 rpm, optionally with a rotor-stator, for a period of time sufficient to form the LUVs.
22. The method of claim 21 , wherein the GMVs are mixed with a rotor-stator.
23. The method of claim 21 , wherein cargo is dissolved in a solvent and combined with i) the giant multi-lamellar vesicles, or ii) LUVs, followed by mixing to form cargo-containing vesicles.
24. The method of claim 14 , wherein the terpene is selected from the group consisting of myrcene, beta caryophyllene, pinene, limonene, terpinolene, humulene, nerolidol, linalool, ocimene, guaiol, bisabolol, alpha phellandrene, cadinene, camphene, camphor, citral, citronellol, delta 3-carene, eucalyptol, eugenol, gamma terpinene, geraniol, humulene, nerol, nerolidol, ocimene, para-cymene, phytol, pulegone, terpineol, valencene, mixtures thereof and pharmaceutically acceptable salts thereof.
25. Giant multi-lamellar vesicles consisting of deoiled lecithin, wherein the lecithin comprises phosphatidylcholines (PC) and phosphatidylethanolamines (PE) with a PC:PE molar or mass ratio of greater than 1, 5-25% by wt PE and less than 10% by wt phosphatidic acids, and wherein the vesicles are 3-10 μm in size.
26. The vesicles of claim 1 , wherein the phospholipid content of the vesicles is greater than 50% by weight.
27. The multi-lamellar vesicles of claim 25 , wherein the phospholipid content of the vesicles is greater than 50% by weight.